Company / Assets per Share
Vivos Therapeutics, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.27
FY2025
5-year range
$0.60 / $14.90
FY2021-FY2025
Trend
-48.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $14.90 to $4.27 over the past 2 years.
Based on SEC 10-K filings.
4.27 in FY2025 with a 5-year CAGR of +16.0%.
Declined from $14.90 to $4.27 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +92.8%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 48.8% year-over-year.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.27 | -48.8% |
| FY2024 | $8.33 | -44.1% |
| FY2023 | $14.90 | +2399.7% |
| FY2022 | $0.60 | -67.8% |
| FY2021 | $1.85 | -9.1% |
| FY2020 | $2.04 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026